Holen Sie sich die Stockscreener-App
0.0334
42.92%
-0.033
Schlusskurs vom Vortag:
$0.0664
Offen:
$0.0319
24-Stunden-Volumen:
601.72K
Relative Volume:
66.00
Marktkapitalisierung:
$N/A
Einnahmen:
$4.02M
Nettoeinkommen (Verlust:
$-4.73M
KGV:
-0.00793
EPS:
-4.21
Netto-Cashflow:
$-5.85M
1W Leistung:
-42.92%
1M Leistung:
-97.38%
6M Leistung:
-99.44%
1J Leistung:
-99.75%
1-Tages-Spanne:
$0.029
$0.035
1-Wochen-Bereich:
$0.029
$0.035
52-Wochen-Spanne:
$0.029
$0.035
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
Vergleichen Sie PTPI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.0334 | 0 | 4.02M | -4.73M | -5.85M | -4.21 |
|
ZTS
Zoetis Inc
|
170.16 | 75.08B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
11.07 | 51.07B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.96 | 46.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.77 | 19.24B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
325.82 | 14.38B | 2.99B | 1.21B | 1.13B | 25.06 |
Petros Pharmaceuticals Inc Aktie (PTPI) Neueste Nachrichten
Petros Pharmaceuticals enhances AI for Rx-to-OTC switch platform By Investing.com - Investing.com Nigeria
Petros Pharmaceuticals modifies terms with investors - MSN
Petros Pharmaceuticals, Inc.(OTCPK: PTPI) dropped from S&P TMI Index - marketscreener.com
PTPI stock plunges to 52-week low, touches $0.07 By Investing.com - Investing.com India
PTPI stock plunges to 52-week low, touches $0.07 - Investing.com Australia
Petros Pharmaceuticals to be delisted from Nasdaq - Investing.com Australia
Petros Pharmaceuticals to be delisted from Nasdaq By Investing.com - Investing.com Nigeria
Petros Pharmaceuticals (PTPI) to Transition from Nasdaq to OTC M - GuruFocus
Petros Pharmaceuticals Faces Nasdaq Delisting Notice - TipRanks
Petros Pharmaceuticals to appeal Nasdaq delisting decision - Investing.com
Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets - ACCESS Newswire
Petros Pharmaceuticals Faces NASDAQ Delisting Despite $10M Cash Position, Plans Appeal - Stock Titan
Petros Pharmaceuticals (PTPI) Teams Up with Innolitics for SaaS Platform Development - GuruFocus
Petros Pharmaceuticals partners with Innolitics for SaaS platform - Investing.com
Petros Pharmaceuticals (PTPI) Teams Up with Innolitics for SaaS Development | PTPI Stock News - GuruFocus
Petros Pharmaceuticals partners with Innolitics for SaaS platform By Investing.com - Investing.com UK
Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer - ACCESS Newswire
Petros Partners with Innolitics: $10M Cash Powers Game-Changing OTC Drug Development Platform - Stock Titan
Analysts Predict How High Petros Pharmaceuticals Inc (PTPI) Will Go. - Stocksregister
Petros Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - ACCESS Newswire
Petros Pharmaceuticals enhances AI for Rx-to-OTC switch platform - Investing.com
Petros Pharmaceuticals (PTPI) Boosts AI Platform with Advanced F - GuruFocus
Petros Pharmaceuticals (PTPI) Boosts AI Platform with Advanced Features | PTPI Stock News - GuruFocus
Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform - ACCESS Newswire
Petros Pharma Upgrades AI Platform Following Trump Order to Expand OTC Drug Access - Stock Titan
Petros Pharmaceuticals Announces Reverse Stock Split - Investing.com India
Petros Pharmaceuticals Announces Reverse Stock Split By Investing.com - Investing.com Australia
Petros Pharma Stock Plunges To Record Low On 1-For-25 Reverse Split, But Retail Optimism Lingers - Asianet Newsable
Petros Pharmaceuticals (PTPI) Aims to Transform with Innovative Healthcare Platform | PTPI Stock News - GuruFocus
Petros Pharmaceuticals pivots to smart healthcare tech By Investing.com - Investing.com India
Petros Pharmaceuticals pivots to smart healthcare tech - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Trump Healthcare Initiative Drives Petros Pharma's $38B AI Platform Innovation for OTC Drug Approvals - Stock Titan
Petros Pharmaceuticals (PTPI) Aligns with Regulatory Climate Und - GuruFocus
Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Provider - ACCESS Newswire
You might want to take a look at Petros Pharmaceuticals Inc (PTPI) now - Sete News
Trump Order To Improve Making More Drugs Available OTC Puts Wind Behind Petros’ ACNU Sails - insights.citeline.com
Petros Pharmaceuticals gears up for Rx-to-OTC switch platform - Investing.com
Petros Pharmaceuticals to effect 1-for-25 reverse stock split - TipRanks
PTPI Announces Reverse Stock Split at 1-for-25 Ratio | PTPI Stoc - GuruFocus
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - Benzinga
Petros Pharmaceuticals gears up for Rx-to-OTC switch platform By Investing.com - Investing.com UK
Trump Executive Order Validates Petros' AI Technology Platform for Revolutionary Drug Access Reform - Stock Titan
Petros Pharmaceuticals (PTPI) Stock Soars 45% Over the Week - GuruFocus
Petros Pharmaceuticals (PTPI) Enhances Rx-to-OTC Platform with A - GuruFocus
PTPI’s Stock Market Adventure: -79.26% YTD Growth Amidst Volatility - investchronicle.com
PTPI Stock Plummets, But Premarket Hints at a Possible Rebound - Own Snap
Finanzdaten der Petros Pharmaceuticals Inc-Aktie (PTPI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.50%
Kapitalisierung:
|
Volumen (24h):